Examples of 'lipegfilgrastim' in a sentence
Meaning of "lipegfilgrastim"
Lipegfilgrastim: A medication used to stimulate the production of white blood cells after chemotherapy
How to use "lipegfilgrastim" in a sentence
Basic
Advanced
lipegfilgrastim
Lonquex contains the active substance lipegfilgrastim.
Lipegfilgrastim is a sustained duration form of filgrastim due to decreased renal clearance.
There is no evidence that lipegfilgrastim is teratogenic.
Lonquex is a medicine that contains the active substance lipegfilgrastim.
A trend towards a decrease in lipegfilgrastim exposure was observed with increase in weight.
There is no experience with overdose of lipegfilgrastim.
Treatment with lipegfilgrastim does not preclude thrombocytopenia and anaemia caused by myelosuppressive chemotherapy.
No neutralising antibodies against lipegfilgrastim were observed.
Concomitant use of lipegfilgrastim with any chemotherapeutic medicinal product has not been evaluated in patients.
The active substance is lipegfilgrastim.
Lipegfilgrastim is metabolised via intra - or extracellular degradation by proteolytic enzymes.
Increased risk of disease progression or death was not observed with lipegfilgrastim.
No lipegfilgrastim therapy should be commenced in these patients because of the risk of cross-reaction.
Median serum concentration of lipegfilgrastim ng / ml.
Lipegfilgrastim appears to be mainly eliminated by neutrophil-mediated clearance, which becomes saturated at higher doses.
See also
Elevation in white blood cells ( WBC ) is consistent with the pharmacodynamic effects of lipegfilgrastim.
Lipegfilgrastim binds to human the G-CSF receptor like filgrastim and pegfilgrastim.
Each ml of solution for injection contains 10 mg of lipegfilgrastim.
Lipegfilgrastim is a long-acting modified protein produced by biotechnology in bacteria called Escherichia coli.
Each pre-filled syringe contains 6 mg lipegfilgrastim.
Lipegfilgrastim may also cause reversible thrombocytopenia see section 4.8.
Study days, injection of lipegfilgrastim at day 0.
Package leaflet, Information for the user Lonquex 6 mg solution for injection in pre-filled syringe lipegfilgrastim.
Therefore, lipegfilgrastim is not likely to affect metabolism via human cytochrome P450 enzymes.
Each ml of solution contains 10 mg lipegfilgrastim.
Each pre-filled syringe contains 6 mg lipegfilgrastim. Each ml solution contains 10 mg lipegfilgrastim.
Lonquex 6 mg solution for injection in pre-filled syringe Lipegfilgrastim.
Patients were randomised 1:1 to receive 6 mg lipegfilgrastim or 6 mg pegfilgrastim.
Patients were randomised 2:1 to receive either 6 mg lipegfilgrastim or placebo.
If WBC counts exceed 50 x 109/l after the expected nadir, lipegfilgrastim should be discontinued immediately.
Lonquex 6 mg injection Lipegfilgrastim.
